Vincenza Colonna

Vincenza Colonna

Auto-generated profile, based on publicly available information

Vincenza Colonna

Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2015 in Nature
Verified
Journal Article
Open access
PDF file
TCThe 1000 Genomes Project Consortium
The 1000 Genomes Project Consortium
AAAdam Auton
Adam Auton
GAGonçalo R. Abecasis
Gonçalo R. Abecasis
SCSteering committee
Steering committee
DADavid M. Altshuler
David M. Altshuler
WGWriting group
Writing group
The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations. Here we report completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-genome sequencing, deep exome sequencing, and dense microarray genotyping. We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), 3.6 million short insertions/deletions (indels), and 60,000 structural variants), all phased onto high-quality haplotypes. This resource includes >99% of SNP variants with a frequency of >1% for a variety of ancestries. We describe the distribution of genetic variation across the global sample, and discuss the implications for common disease studies.

10 May 2023 in Nature
Verified
Journal Article
Open access
PDF file
WLWen-Wei Liao
Wen-Wei Liao
MAMobin Asri
Mobin Asri
JEJana Ebler
Jana Ebler
DDDaniel Doerr
Daniel Doerr
MHMarina Haukness
Marina Haukness
BPBenedict Paten
Benedict Paten
Here the Human Pangenome Reference Consortium presents a first draft of the human pangenome reference. The pangenome contains 47 phased, diploid assemblies from a cohort of genetically diverse individuals1. These assemblies cover more than 99% of the expected sequence in each genome and are more than 99% accurate at the structural and base pair levels. Based on alignments of the assemblies, we generate a draft pangenome that captures known variants and haplotypes and reveals new alleles at structurally complex loci. We also add 119 million base pairs of euchromatic polymorphic sequences and 1,115 gene duplications relative to the existing reference GRCh38. Roughly 90 million of the additional base pairs are derived from structural variation. Using our draft pangenome to analyse short-read data reduced small variant discovery errors by 34% and increased the number of structural variants detected per haplotype by 104% compared with GRCh38-based workflows, which enabled the typing of the vast majority of structural variant alleles per sample.

25 March 2012 in Nature
Verified
Journal Article
Open access
PDF file
TIThe GenISIS Investigators
The GenISIS Investigators
AEAaron R. Everitt
Aaron R. Everitt
MSMalcolm Gracie Semple
Malcolm Gracie Semple
SCSimon Clare
Simon Clare
TPThomas Pertel
Thomas Pertel
PKPaul Kellam
Paul Kellam
Interferon-inducible transmembrane (IFITM) protein 3 is shown to be an innate defence mechanism against viral infection in vivo; furthermore, a subset of the patients hospitalized during the H1N1 2009 pandemic carried a variant form of the IFITM3 gene. Interferon-inducible transmembrane (IFITM) proteins restrict the replication of certain pathogenic viruses, but no in vivo role for these proteins has been known until now. Paul Kellam and colleagues now report that IFITM3 is essential for protecting mice infected with influenza viruses from developing fulminant viral pneumonia. The authors further find that a small subset of humans hospitalized for infection with pandemic H1N1/09 swine flu or seasonal influenza virus carried a variant of IFITM3 with reduced antiviral activity. These results suggest that IFITM3 has a pivotal role in defence against influenza infection. The 2009 H1N1 influenza pandemic showed the speed with which a novel respiratory virus can spread and the ability of a generally mild infection to induce severe morbidity and mortality in a subset of the population. Recent in vitro studies show that the interferon-inducible transmembrane (IFITM) protein family members potently restrict the replication of multiple pathogenic viruses1,2,3,4,5,6,7. Both the magnitude and breadth of the IFITM proteins’ in vitro effects suggest that they are critical for intrinsic resistance to such viruses, including influenza viruses. Using a knockout mouse model8, we now test this hypothesis directly and find that IFITM3 is essential for defending the host against influenza A virus in vivo. Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normally low-pathogenicity influenza virus, mirroring the destruction inflicted by the highly pathogenic 1918 ‘Spanish’ influenza9,10. Similar increased viral replication is seen in vitro, with protection rescued by the re-introduction of Ifitm3. To test the role of IFITM3 in human influenza virus infection, we assessed the IFITM3 alleles of individuals hospitalized with seasonal or pandemic influenza H1N1/09 viruses. We find that a statistically significant number of hospitalized subjects show enrichment for a minor IFITM3 allele (SNP rs12252-C) that alters a splice acceptor site, and functional assays show the minor CC genotype IFITM3 has reduced influenza virus restriction in vitro. Together these data reveal that the action of a single intrinsic immune effector, IFITM3, profoundly alters the course of influenza virus infection in mouse and humans.

4 October 2013 in Science
Verified
Journal Article
Closed access
PDF file
EKEkta Khurana
Ekta Khurana
YFYao Fu
Yao Fu
VCVincenza Colonna
Vincenza Colonna
XMXinmeng Jasmine Mu
Xinmeng Jasmine Mu
HKHyun Min Kang
Hyun Min Kang
MGMark Gerstein
Mark Gerstein
Identifying Important Identifiers: Each of us has millions of sequence variations in our genomes. Signatures of purifying or negative selection should help identify which of those variations is functionally important. Khurana et al. ( 1235587 ) used sequence polymorphisms from 1092 humans across 14 populations to identify patterns of selection, especially in noncoding regulatory regions. Noncoding regions under very strong negative selection included binding sites of some chromatin and general transcription factors (TFs) and core motifs of some important TF families. Positive selection in TF binding sites tended to occur in network hub promoters. Many recurrent somatic cancer variants occurred in noncoding regulatory regions and thus might indicate mutations that drive cancer.

21 October 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
EGErik Garrison
Erik Garrison
AGAndrea Guarracino
Andrea Guarracino
SHSimon Heumos
Simon Heumos
FVFlavia Villani
Flavia Villani
ZBZhigui Bao
Zhigui Bao
PPPjotr Prins
Pjotr Prins

30 June 2014 in Genome Biology
Verified
Journal Article
Open access
PDF file
VCVincenza Colonna
Vincenza Colonna
QAQasim Ayub
Qasim Ayub
YCYuan Chen
Yuan Chen
LPLuca Pagani
Luca Pagani
PLPierre Luisi
Pierre Luisi
CTChris Tyler-Smith
Chris Tyler-Smith
Background: Population differentiation has proved to be effective for identifying loci under geographically localized positive selection, and has the potential to identify loci subject to balancing selection. We have previously investigated the pattern of genetic differentiation among human populations at 36.8 million genomic variants to identify sites in the genome showing high frequency differences. Here, we extend this dataset to include additional variants, survey sites with low levels of differentiation, and evaluate the extent to which highly differentiated sites are likely to result from selective or other processes. Results: We demonstrate that while sites with low differentiation represent sampling effects rather than balancing selection, sites showing extremely high population differentiation are enriched for positive selection events and that one half may be the result of classic selective sweeps. Among these, we rediscover known examples, where we actually identify the established functional SNP, and discover novel examples including the genes ABCA12, CALD1 and ZNF804, which we speculate may be linked to adaptations in skin, calcium metabolism and defense, respectively. Conclusions: We identify known and many novel candidate regions for geographically restricted positive selection, and suggest several directions for further research.